| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ral guanine nucleotide dissociation stimulator like 3 | 1.0E-31 |
|
group | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2016 | ||||||||||
|
ring finger and FYVE like domain containing E3 ubiquitin protein ligase | 0.41 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||||
|
phosphoseryl-tRNA kinase | 7.4E-06 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||||
|
transcription elongation factor A N-terminal and central domain containing | 5.2E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||||
|
C-reactive protein pseudogene 1 |
|
group | 0.010 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||||
|
glutathione S-transferase alpha 5 | 1.8E-11 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||||
|
relaxin family peptide/INSL5 receptor 4 | 6.0E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||||
|
eukaryotic translation initiation factor 4B pseudogene 8 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||||
|
olfactory receptor family 5 subfamily B member 12 | 2.0E-02 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||||
|
leucine rich repeat containing 10B | 4.5E-02 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||||
|
oxidative stress responsive serine rich 1 | 2.9E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||||
|
preeclampsia/eclampsia 1 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | |||||||||||
|
Nedd4 family interacting protein 2 | 0.53 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||||
|
haloacid dehalogenase like hydrolase domain containing 2 | 3.9E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||||
|
G protein-coupled receptor 75 | 1.000 | 0.038 | 1.6E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
transcription activation suppressor | 1.000 | 0.038 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
integrin subunit beta 1 binding protein 2 | 0.821 | 0.038 | 2.6E-08 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
human papillomavirus (type 18) integration site 2 | 0.931 | 0.038 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
caveolae associated protein 4 | 0.890 | 0.038 | 5.1E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
CD164 molecule like 2 | 1.000 | 0.038 | 1.1E-05 |
|
group | 0.010 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
transmembrane protein 212 | 1.000 | 0.038 | 1.8E-08 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
spermatogenesis associated 6 | 0.931 | 0.038 | 3.4E-21 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
long intergenic non-protein coding RNA 862 | 1.000 | 0.038 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
inflammatory bowel disease 7 | 1.000 | 0.038 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
transmembrane protein 38A | 1.000 | 0.038 | 5.8E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 |